Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgain AMS on Instagram


  • Decreasing the risk of falls and fractures before, during and after menopause
    MAIN POINTS Falls and fractures can happen at any age, but the risk increases as women age. Falls in older people are more likely to cause more severe injuries. Low bone density, low muscle strength and poor balance are more likely as women age and increase the risk of falls. Improving your bo... Read more..
  • The Basics: HT Dose, Route, Formulations
    Dr Gloria Richard-Davis, executive director, Division of Diversity, Equity, and Inclusion, and professor in the Department of Obstetrics and Gynecology at the University of Arkansas for Medical Sciences Dr Richard-Davis discusses considerations when prescribing hormone therapies Read more..
  • MHT & breast cancer
    September 2019:   There is a known association between the use of menopausal hormone therapy (MHT) and breast cancer.  An article by Beral et al for the Collaborative Group on Hormonal Factors in Breast Cancer (Lancet 2019 doi: 10.1016/S0140-6736(19)31709-X) attempts to quantify the ... Read more..
  • Position Statement on Improving Bone Health and Osteoporosis Management in Australia
    The Position Statement on Improving Bone Health and Osteoporosis Management in Australia was developed as a result of the Inaugural National Consumer and Community Forum, held on 20 November 2020, and provides specific recommendations and actions to improve the diagnosis and management of ... Read more..
  • Vitamin D and Omega-3s in Midlife Health
    Dr JoAnn Manson Vhief of the Division of Preventive Medicine at Brigham and Women’s Hospital; Professor of medicine and the Michael and Lee Bell Professor of Women’s Health at Harvard Medical School, Boston, Massachusetts; and NAMS Past-President. Dr JoAnn Manson discusses the role of supplements ... Read more..
  • What’s new - The use of testosterone in women
    The AMS Board is pleased to bring you this webinar recording on the use of testosterone therapy in women. This webinar is targeted at GPs, endocrinologists, gynaecologists, pharmacists and other healthcare professionals. This presentation will include a review of basic female androgen physiology, wh... Read more..
  • New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
    Launch of first pan-Asia Pacific minimum clinical standards for the screening, diagnosis & management of osteoporosis The Asia Pacific Consortium on Osteoporosis (APCO) has today (Thursday, January 28, 2021) launched the first pan-Asia Pacific clinical practice standards for the screenin... Read more..
  • Capture the Fracture® Partnership
    16 June 2020:   NYON, Switzerland International Osteoporosis Foundation Announces First-of-its-Kind Partnership With University of Oxford, Amgen and UCB to Combat Global Public Health Burden of Osteoporosis (1)  Hip and Vertebral Fractures are Costly for Society and Can be LifeAlter... Read more..
  • COMMA (Core Outcome Set for Menopausal Symptoms)
    COMMA (Core Outcome Set for Menopausal Symptoms) is inviting clinicians, researchers and women who have experienced menopause around the world to provide input on what symptoms should be measured in trials of treatments for menopausal symptoms. Clinical trials for menopausal symptoms have measured a... Read more..
  • Maintaining your weight and health during and after menopause
    MAIN POINTS Weight gain during and after menopause has more to do with your lifestyle and the changes of ageing than with hormonal changes of menopause. The hormonal changes of menopause can cause fat to settle in your abdomen rather than your hips, thighs and buttocks. Menopausal Hormone Treat... Read more..
  • Early menopause – chemotherapy and radiation therapy
    MAIN POINTS Chemotherapy and radiation therapy for cancer and other conditions can cause temporary or permanent loss of your menstrual periods and menopause. Before the age of 40, this is known as premature ovarian insufficiency (POI). Between the ages of 40 and 45, this is known as early menop... Read more..
  • Oestrogen and cognition in the perimenopause and menopause
    Key Points Women commonly report memory or cognition changes associated with the menopause transition and menopause. Women may refer to this as ‘brain fade’ or ‘brain fog’. However, the contributing roles of menopause related to oestrogen decline, aging, effect of co-morbidities, psycho-... Read more..
  • HRT and Breast Cancer Risk Position Statement
    A joint statement has been issued by the British Menopause Society, the International Menopause Society, the European Menopause and Andropause Society, the Royal College of Obstetricians and Gynaecologists and the Australasian Menopause Society on menopausal hormone therapy (MHT) and breast cancer r... Read more..
  • AMS eLearning Website access
    AMS has made the AMS eLearning site easier to access for all members. All members who were not registered on the site have now been added at https://elearning.menopause.org.au/ and pre-enrolled in all available courses. Members who were already registered on the site have now been pre-en... Read more..
  • Early Menopause: New digital resources for women and health professionals
    Two comprehensive new Australian digital resources have been developed for women with early menopause / primary ovarian insufficiency (POI) and health professionals caring for women with EM / POI. Located on the Healthtalk Australia website, the resources feature women’s and health professionals’ e... Read more..
  • Vietnamese: What is Menopausal Hormone Therapy (MHT) and is it safe?
    Download Infographic: What is Menopausal Hormone Therapy (MHT) and is it safe? Vietnamese794.1 KB         If you have any concerns or questions about options to manage your menopausal symptoms, visit your doctor or go to the Find an AMS Doctor service on the AMS webs... Read more..
  • Endometriosis – management after menopause
    Key Points Medical management with either the combined oral contraceptive pill or treatments that create a hypo-oestrogenic state are used in premenopausal women. Evidence is sparse but current recommendations favour continuous combined oestrogen- progestogen preparations instead o... Read more..
  • Breast Cancer and Menopause
    Key Points Menopause/menopausal symptoms in women with breast cancer have a significant negative impact on quality of life, with both short- and long-term health consequences. Management of menopause in women with breast cancer is directed at relieving troublesome symptoms and mini... Read more..
  • Migraine headaches, menopause and MHT/HRT
    KEY POINTS Migraine is not a contraindication to using menopausal hormone therapy Migraine without aura is more sensitive to hormonal flux than migraine with aura Falling oestrogen commonly triggers the onset of a hormonally sensitive migraine Maintaining stable oestrogen levels is imp... Read more..
  • Advances in Our Understanding of the Etiology/Mechanisms of Vasomotor Symptoms
    Dr Rebecca Thurston Director of the Women’s Biobehavioral Health Laboratory and Professor of Psychiatry, Psychology, Epidemiology, and Clinical and Translational Science at the University of Pittsburgh. Dr Thurston discusses the science behind vasomotor symptoms. Read more..

Print Email


Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgainAMS on Instagram